US stock screener
Every US-listed company we cover. Most columns are company-reported figures from each company’s own SEC filings; P/E, market cap and dividend yield are market-derived, combining SEC share counts and TTM results with a stored price, last retrieved on a rolling basis and typically within the past week. Click a column to sort, or open a company for its full statements with per-figure provenance.
All sectorsTechnologyFinancialsHealthcareConsumer DiscretionaryConsumer StaplesEnergyIndustrialsMaterialsUtilitiesReal EstateCommunication Services
558 companies in Healthcare · page 6 of 6
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | Healthcare | $65.2Mvendor | $13.0M | 15.4% | — | -53.7% | — | — |
| Evommune, Inc. (EVMN) | Healthcare | $445.3Mpit | $13.0M | 85.7% | — | -33.5% | — | — |
| Emmaus Life Sciences, Inc. (EMMA) | Healthcare | $5.0Mpit | $12.5M | -25.2% | -60.2% | — | — | — |
| ELUTIA INC. (ELUT) | Healthcare | $36.8Mpit | $12.3M | -15.0% | — | 192.9% | — | — |
| Prelude Therapeutics Inc (PRLD) | Healthcare | $435.7Mpit | $12.1M | 73.4% | — | -145.0% | — | — |
| ESCALON MEDICAL CORP (ESMC) | Healthcare | $1.3Mpit | $12.0M | 0.5% | 0.9% | 5.5% | — | — |
| Cardiff Lexington Corp (CDIX) | Healthcare | $3.1Mpit | $11.5M | 39.5% | -47.7% | — | — | — |
| Jaguar Health, Inc. (JAGX) | Healthcare | $3.1Mpit | $11.5M | -1.5% | — | — | — | — |
| LogicMark, Inc. (LGMK) | Healthcare | $1.1Mpit | $11.4M | 15.4% | -65.4% | — | — | — |
| NEXGEL, INC. (NXGL) | Healthcare | $3.1Mpit | $11.4M | 31.5% | -26.3% | -61.3% | — | — |
| Caribou Biosciences, Inc. (CRBU) | Healthcare | $171.5Mpit | $11.2M | 11.7% | — | -121.2% | — | — |
| CRESCENT BIOPHARMA, INC. (CBIO) | Healthcare | $757.7Mpit | $10.8M | — | — | -75.8% | — | — |
| TScan Therapeutics, Inc. (TCRX) | Healthcare | $23.4Mpit | $10.3M | 266.7% | — | -105.4% | — | — |
| Alpha Cognition Inc. (ACOG) | Healthcare | $207.3Mpit | $10.2M | — | — | -33.1% | — | — |
| Janux Therapeutics, Inc. (JANX) | Healthcare | $1.24Bpit | $10.0M | -5.6% | — | -11.9% | — | — |
| Zenas BioPharma, Inc. (ZBIO) | Healthcare | $2.14Bpit | $10.0M | 100.0% | — | -156.0% | — | — |
| WORK Medical Technology Group LTD (WOK) | Healthcare | $9.2Mvendor | $9.8M | -14.4% | -10.9% | -5.1% | — | — |
| Taysha Gene Therapies, Inc. (TSHA) | Healthcare | $1.82Bpit | $9.8M | 17.3% | — | -44.1% | — | — |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Healthcare | $504.1Mpit | $9.7M | -92.8% | — | -87.0% | — | — |
| CURIS INC (CRIS) | Healthcare | $2.9Mpit | $9.4M | -13.4% | -80.3% | -138.8% | — | — |
| Aspira Women's Health Inc. (AWHL) | Healthcare | $13.1Mpit | $9.2M | 0.4% | — | — | — | — |
| Roivant Sciences Ltd. (ROIV) | Healthcare | $29.96Bpit | $8.3M | -71.6% | — | -5.7% | — | — |
| Aclaris Therapeutics, Inc. (ACRS) | Healthcare | $908.2Mpit | $7.8M | -58.2% | — | -63.0% | — | — |
| Adagene Inc. (ADAG) | Healthcare | $240.4Mvendor | $7.7M | 7332.8% | — | — | — | — |
| Whitehawk Therapeutics, Inc. (WHWK) | Healthcare | $262.2Mpit | $7.1M | -72.5% | — | -15.1% | — | — |
| Immunome Inc. (IMNM) | Healthcare | $3.04Bpit | $6.9M | -23.2% | — | -33.5% | — | — |
| FATE THERAPEUTICS INC (FATE) | Healthcare | $290.0Mpit | $6.6M | -51.2% | — | -65.8% | — | — |
| KYNTRA BIO, INC. (KYNB) | Healthcare | $34.6Mpit | $6.4M | -78.3% | — | — | 0.2 | — |
| DBV Technologies S.A. (DBVT) | Healthcare | $846.5Mvendor | $5.6M | 35.8% | — | -87.1% | — | — |
| SCIENTIFIC INDUSTRIES INC (SCND) | Healthcare | $9.5Mpit | $5.1M | 5.4% | -24.1% | -11.4% | — | — |
| NewGenIvf Group Ltd (NIVF) | Healthcare | $2.4Mvendor | $4.7M | -13.0% | — | 38.0% | — | — |
| ProPhase Labs, Inc. (PRPH) | Healthcare | $311,851pit | $4.3M | -35.8% | — | -420.3% | — | — |
| CRISPR Therapeutics AG (CRSP) | Healthcare | $5.39Bpit | $3.5M | -90.6% | — | -30.3% | — | — |
| Surrozen, Inc./DE (SRZN) | Healthcare | $267.5Mpit | $3.5M | -67.4% | — | — | — | — |
| Cartesian Therapeutics, Inc. (RNAC) | Healthcare | $280.5Mpit | $2.8M | -92.8% | — | — | — | — |
| CollPlant Biotechnologies Ltd (CLGN) | Healthcare | $645,147vendor | $2.4M | 360.4% | — | -188.9% | — | — |
| Lipocine Inc. (LPCN) | Healthcare | $20.2Mpit | $2.0M | -82.3% | — | -66.5% | — | — |
| Silence Therapeutics plc (SLN) | Healthcare | $689.3Mpit | $559,000 | -98.7% | — | -142.2% | — | — |
| Mereo BioPharma Group plc (MREO) | Healthcare | $39.9Mpit | $500,000 | — | — | -102.4% | — | — |
| Connect Biopharma Holdings Ltd (CNTB) | Healthcare | $173.8Mpit | $64,000 | -99.8% | — | -132.2% | — | — |
| Amylyx Pharmaceuticals, Inc. (AMLX) | Healthcare | $3.80Bpit | $0 | -100.0% | — | -47.4% | — | — |
| Artiva Biotherapeutics, Inc. (ARTV) | Healthcare | $531.9Mpit | $0 | -100.0% | — | -76.3% | — | — |
| Barinthus Biotherapeutics plc. (BRNS) | Healthcare | $29.4Mpit | $0 | -100.0% | — | -89.4% | — | — |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | Healthcare | $575.0Mpit | $0 | -100.0% | — | -34.4% | — | — |
| Denali Therapeutics Inc. (DNLI) | Healthcare | $3.56Bpit | $0 | — | — | -50.6% | — | — |
| Fulcrum Therapeutics, Inc. (FULC) | Healthcare | $293.0Mpit | $0 | -100.0% | — | -21.5% | — | — |
| KIORA PHARMACEUTICALS INC (KPRX) | Healthcare | $11.3Mpit | $0 | -100.0% | — | -67.2% | — | — |
| Lite Strategy, Inc. (LITS) | Healthcare | $35.4Mpit | $0 | -100.0% | — | -94.2% | — | — |
| Revolution Medicines, Inc. (RVMD) | Healthcare | $44.44Bpit | $0 | — | — | -69.3% | — | — |
| SPRUCE BIOSCIENCES, INC. (SPRB) | Healthcare | $166.5Mpit | $0 | -100.0% | — | -91.7% | — | — |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | Healthcare | $286.0Mpit | $0 | -100.0% | — | -63.4% | — | — |
| Contineum Therapeutics, Inc. (CTNM) | Healthcare | $599.7Mpit | — | — | — | -23.0% | — | — |
| Equillium, Inc. (EQ) | Healthcare | $140.8Mpit | — | — | — | -78.3% | — | — |
| Maze Therapeutics, Inc. (MAZE) | Healthcare | $1.44Bpit | — | — | — | -36.9% | — | — |
| PALVELLA THERAPEUTICS, INC. (PVLA) | Healthcare | $2.27Bpit | — | — | — | -149.1% | — | — |
| Stablecoin Development Corp (SDEV) | Healthcare | $45.0Mpit | — | — | — | — | — | — |
| Tvardi Therapeutics, Inc. (TVRD) | Healthcare | $25.5Mpit | — | — | — | -87.0% | — | — |
| VERU INC. (VERU) | Healthcare | $45.0Mpit | — | — | — | -124.0% | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR, as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.